DISEASE INDICATIONS: Psoriasis

MANUFACTURER: Almirall, S.A.

USAGE: Oral

MEDICINE APPROVED BY: European Medical Agency (EMA)

Skilarence is a medication used to treat moderate to severe plaque psoriasis in adults. Developed by Almirall, it works by reducing inflammation and cell proliferation in the affected skin cells. It has been approved by the European Medicines Agency and found safe for use in clinical trials.